Cardiac Arrhythmia Drugs Flashcards
State the common causes of arrhythmias
- Arrhythmia due to disturbances in pacemaker impulse formation (SA/AV node), contraction impulse conduction (bundle of His) or a combination of the two
- Results in rate/timing of contraction of heart muscle that is insufficient to maintain normal cardiac output
Describe how abnormal impulse generation leads to arrhythmias
- Can be automatic rhythms
- Enhanced normal automaticity - increased action potential from SA node (such as when scared)
- Ectopic focus - action potential arises from sites other than SA node
- Can occur in areas of infarcts where damaged myocardium becomes depolarised and spontaneously active
- Triggered rhythms
- Delayed afterdepolarisation - arises fro the resting potential
- Early afterdepolarisation - arises from the plateau phase commonly with a prolonged plateau phase
- Drugs should either decrease funny current slope or increase the threshold
Describe how abnormal electrical conduction can lead to arrhythmias
- Conduction block (1st, 2nd, 3rd degree)
- When the impulse is not conducted from the atria to the ventricles
- Treated by pacemakers
- Re-entry loop
- Wolff-Parkinson-White syndrome (WPW)
- An accessory pathway in the heart called Bundle of Kent can cause a constant re-entry loop
- Wolff-Parkinson-White syndrome (WPW)
- Drugs should either decrease conduction velocity or increase refractory period
Briefly describe the effects of blocking the different channels with anti-arrhythmic drugs
- Blocking Na channels
- Marked slowing conduction in tissue (phase 0) - shifts curve to right
- Minor effects on action potential duration
- Marked slowing conduction in tissue (phase 0) - shifts curve to right
- Beta-blockers
- Diminish phase 4 depolarisation and automaticity
- Increase action potential duration
- Decrease slope of pacemaker potential in SA and slow conduction at AV node
- Reduce funny current and reduce opening of Ca channels
- Blocking potassium channels
- Increase action potential duration by prolonging refractory period - Blocking calcium channels
- Calcium channel blockers decrease inward calcium currents resulting in a decrease of phase 4 spontaneous depolarisation
- Increases refractory period of SA node action potentials - slows down action potentials
Describe the effect of class 1A agents on the heart
- Eg. Procainamide, quinidine, disopyramide
- Effects on cardiac activity
- Decrease conduction by decreasing depolarisation in ventricular cells
- Increase refractory period (increase action potential duration and sodium inactivation) - indirect effect on potassium channels
- Decrease automaticity (decrease slope of funny current)
- Increase threshold of sodium
- Effects on ECG - increase QRS interval, increase QT interval
Describe the uses and side effects of class 1A agents
- Uses
- Wide spectrum
- Quinidine - maintain sinus rhythms in atrial fibrillation and flutter and to prevent recurrence
- Procainamide - acute IV treatment of supraventricular and ventricular arrhythmias
- Side effects
- Hypotension, reduced cardiac output
- Proarrhythmia - if AF causes a usual 2:1 AV node response (ie 150bpm if 300bpm from SA node), a sudden decrease in SA node potential frequency causes 1:1 AV node response, thus leading to ventricular fibrillation
- Torsades de Points - longer QT interval leading to arrhythmia
- Dizziness, confusion, insomnia, seizure (high dose)
- GI effects
- Lupus-like syndrome (especially procainamide)
Describe the effects of class 1B agents on the heart
- Effects on cardiac activity
- Increased threshold of sodium
- Decreased sodium depolarisation in fast beating or ischaemic tissue
- Decreases length of refractory period and action potential
- Effects on ECG
- Increase QRS in fast beating or ischaemic tissue only
Describe the uses and side effects of class 1B agents
- Eg. Lidocaine (IV), mexiletine (oral)
- Uses
- Acute - ventricular tachycardia especially during ischaemia
- Not used in atrial arrhythmias or AV junctional arrhythmias
- Side effects
- CNS effects - dizziness, drowsiness
- Abdominal upset
- CNS effects - dizziness, drowsiness
Describe the effects of class 1C agents on the heart
- Eg. Flecainide, propafenone
- Effects on cardiac activity
- Substantially decreases sodium depolarisation
- Decrease automaticity (increases threshold)
- Increased action potential duration and increased refractory period (lower increase compared to 1A)
- Effects on ECG
- Increased PR interval, increases QRS, increased QT
Describe the uses and side effects of class 1C agents
- Uses
- Wide spectrum
- Used for supraventricular arrhythmias (fibrillation and flutter)
- Premature ventricular contraction - if no ischaemic tissue
- Wolff-Parkinson-White syndrome
- Side effects
- Proarrhythmia and sudden death with chronic use
- Increase ventricular response to supraventricular arrhythmias
- CNS and GI effects
Describe the effects of class II agents on the heart
- Effects on cardiac activity
- Increase action potential duration and refractory period in AV node to slow AV conduction velocity due to opening of calcium channels
- Decrease funny current depolarisation to slow conduction at SA and AV nodes
- Effects on ECG
- Increased PR interval, decreased heart rate
Describe the uses and side effects of class II agents
- Eg. Propanolol (ß1,ß2, oral, IV), bisoprolol (ß2, oral), metoprolol (oral, IV), esmolol (IV)
- Uses
- Treat SA node and catecholamine dependent tachycardia
- Converting reentrant arrhythmias at AV node as reduces AV node entry
- Protecting the ventricles from high atrial rates (slows AV conduction)
- Side effects
- Bronchospasm
- Hypotension
- Do not use in partial AV block or ventricular (heart) failure
Describe the effects of amiodarone on the heart
- Effects on cardiac activity
- Increase refractory period and increases action potential duration
- Decrease depolarisation and sodium conduction
- Increase threshold
- Amiodarone also a ß-blocker and Ca channel blocker - decrease funny current
- Decrease speed of AV conduction
- Effects on ECG
- Increase PR, QRS, QT
- Decreased heart rate
Describe the uses and side effects of amiodarone
- Uses
- Very wide spectrum
- Effective for most arrhythmias
- Wolff-Parkinson-White syndrome
- Side effects - BITCH
- Bradycardia
- Interstitial lung disease (pulmonary fibrosis) - monitor lung function
- Thyroid (hypo and hyper)
- Corneal/cutaneous
- Hepatic injury - monitor liver function/hypotension
Describe the effect of sotalol on the heart
- Effects on cardiac activity
- Increase action potential duration and refractory period in atrial and ventricular tissue
- Slow funny current (ß blocker)
- Slow AV conduction
- Effects on ECG
- Increase QT, decrease heart rate
Describe the uses and side effects of sotalol
- Uses
- Wide spectrum
- Supraventricular and ventricular tachycardia
- Side effects
- Proarrhythmia, fatigue, insomnia
Describe the effects of class IV agents on the heart
- Eg. Verapamil (oral, IV), diltiazem (oral)
- Effects on cardiac activity
- Slow conduction through AV node by blocking calcium channels
- Increased refractory period in AV node
- Effects on ECG
- Increased PR
- Heart rate may increase or decrease depending on blood pressure response and baroreflex
Describe the uses and side effects of class IV agents
- Uses
- Control ventricles during supraventricular tachycardia
- Convert supraventricular tachycardia (re-entry around AV)
- Side effects
- Caution when partial AV block is present - can get asystole if ß-blocker is used
- Hypotension - further decrease cardiac output
- GI problems
Describe the mechanism and effect of adenosine
- Rapid IV bolus - heart is stopped when given and metabolised, then starts again
- Mechanism
- Natural nucleoside binds A1 receptors and activates K currents in AV and SA node
- Decreases action potential duration and causes hyperpolarisation, which decreases heart rate
- Decreases calcium currents - increase refractory period in AV node
- Effects on cardiac activity
- Slows AV conduction
Describe the uses of adenosine
- Convert re-entrant supraventricular arrhythmias
- Hypotension during surgery
- Diagnosis of coronary artery disease - MRI scan of heart and see difference when perfusion re-established
Describe the mechanism of digoxin (cardiac glycosides)
- Digoxin blocks Na/K ATPase
- By blocking Na/K ATPase, sodium concentration inside increases
- NCX activity decreases leads to increase in calcium concentration inside
- Calcium becomes stored in SR via SERCA
- Increase calcium available to be released in action potential and increase force of contraction
- Glycosides also act on neurones in cardiac control centre to increase vagal activity
- Increase potassium currents, decrease calcium currents and increases refractory period
- Slows AV conduction and slows heart rate
- Increase potassium currents, decrease calcium currents and increases refractory period
Describe the uses of digoxin
- Treatment to reduce ventricular rates in atrial fibrillation and flutter
- Used in adjunction to other drugs
State the preferred drugs used to treat supraventricular arrhythmias
- Rate control - slow heart rate by slowing AV node conductance
- Adenosine - can be used after beta blocker unlike verapamil
- Digoxin - slows ventricular response to AF and atrial flutter
- Verapamil - useful in slowing ventricular response to AF but need to watch out if beta blocker given alongside
- Beta blocker - control ventricular rate
- Rhythm control
- Procainamide
- Amiodarone
- Sotalol
- Flecainide
State the preferred drug used to treat Wolff-Parkinson-White syndrome
- Amiodarone
- Flecainide
State the preferred drugs used to treat supraventricular and ventricular arrhythmias and ectopic beats
- Amiodarone - slows AV node conductance and ventricular response
- Beta blockers - slow AV node conductance
- Sotalol - increase refractory period in atrial and ventricular tissue, slow AV conductance
- Flecainide - decrease depolarisation of ventricular tissue
- Procainamide - decrease conductance and increase refractory period in ventricular tissue
State the preferred drugs used to treat ventricular arrhythmias
- Lidocaine - decrease ventricular tissue conductance in ischaemic tissue
- Amiodarone
- Beta blocker
- Flecainide
- Procainamide